Circulating PCSK9 levels correlate with the serum LDL cholesterol level in newborn infants

Early Human Development

Volumn 90, Issue 10, 2014, Pages 607-611

  Araki, Shunsuke ^a,b   Suga, Shutaro ^a,b   Miyake, Fuyu ^a,b   Ichikawa, Shun ^a,b   Kinjo, Tadamune ^a,b   Yamamoto, Yukiyo ^a   Kusuhara, Koichi ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b School of Medicine   (Japan)

Author keywords

LDL C; Metabolic syndrome; Newborn infants; PCSK9; Small for gestational age

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9; SERINE PROTEINASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; PCSK9 PROTEIN, HUMAN;

ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; FEMALE; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; NEWBORN; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SERUM; SMALL FOR DATE INFANT; BLOOD; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; JAPAN; NONPARAMETRIC TEST; SEX DIFFERENCE;

BIRTH WEIGHT; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; JAPAN; MALE; PROPROTEIN CONVERTASES; SERINE ENDOPEPTIDASES; SEX FACTORS; STATISTICS, NONPARAMETRIC;

EID: 84921406031     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2014.07.013     Document Type: Article

References (23)

1. Seidah N.G., Benjannet S., Wickham L., Marcinkiewicz J., Jasmin S.B., Stifani S., et al. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. Proc Natl Acad Sci U S A 2003, 100:928-933.
2. Seidah N.G., Prat A. The proprotein convertases are potential targets in the treatment of dyslipidemia. J Mol Med 2007, 85:685-696.
3. Horton J.D., Cohen J.C., Hobbs H.H. Molecular biology of PCSK9: its role in LDL metabolism. Trends Biochem Sci 2007, 32:71-77.
4. Abifadel M., Varret M., Rabes J.P., Allard D., Ouguerram K., Devillers M., et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 2003, 34:154-156.
5. Cohen J., Pertsemlidis A., Kotowski I.K., Graham R., Garcia C.K., Hobbs H.H. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat Genet 2005, 37:161-165.
6. Mayne J., Raymond A., Chaplin A., Cousins M., Kaefer N., Gyamera-Acheampong C., et al. Plasma PCSK9 levels correlate with cholesterol in men but not in women. Biochem Biophys Res Commun 2007, 361:451-456.
7. Alborn W.E., Cao G., Careskey H.E., Qian Y.W., Subramaniam D.R., Davies J., et al. Serum proprotein convertase subtilisin kexin type 9 is correlated directly with serum LDL cholesterol. Clin Chem 2007, 53:1814-1819.
8. Dubuc G., Tremblay M., Pare G., Jacques H., Hamelin J., Benjannet S., et al. A new method for measurement of total plasma PCSK9: clinical applications. J Lipid Res 2010, 51:140-149.
9. Baass A., Dubuc G., Tremblay M., Delvin E.E., O'Loughlin J., Levy E., et al. Plasma PCSK9 is associated with age, sex, and multiple metabolic markers in a population-based sample of children and adolescents. Clin Chem 2009, 55:1637-1645.
10. Peticca P., Raymond A., Gruslin A., Cousins M., Adetola E., Abujrad H., et al. Human serum PCSK9 is elevated at parturition in comparison to nonpregnant subjects while serum PCSK9 from umbilical cord blood is lower compared to maternal blood. ISRN Endocrinol 2013, 2013:341632.
11. Nagasaka H., Chiba H., Kikuta H., Akita H., Takahashi Y., Yanai H., et al. Unique character and metabolism of high density lipoprotein (HDL) in fetus. Atherosclerosis 2002, 161:215-223.
12. Averna M.R., Barbagallo C.M., Di Paola G., Labisi M., Pinna G., Marino G., et al. Lipids, lipoproteins and apolipoproteins AI, AII, B, CII, CIII and E in newborns. Biol Neonate 1991, 60:187-192.
13. Loughrey C.M., Rimm E., Heiss G., Rifai N. Race and gender differences in cord blood lipoproteins. Atherosclerosis 2000, 148:57-65.
14. Kelishadi R., Badiee Z., Adeli K. Cord blood lipid profile and associated factors: baseline data of a birth cohort study. Paediatr Perinat Epidemiol 2007, 21:518-524.
15. Bansal N., Cruickshank J.K., McElduff P., Durrington P.N. Cord blood lipoproteins and prenatal influences. Curr Opin Lipidol 2005, 16:400-408.
16. Lakoski S.G., Lagace T.A., Cohen J.C., Horton J.D., Hobbs H.H. Genetic and metabolic determinants of plasma PCSK9 levels. J Clin Endocrinol Metab 2009, 94:2537-2543.
17. Evans D., Beil F.U. The E670G SNP in the PCSK9 gene is associated with polygenic hypercholesterolemia in men but not in women. BMC Med Genet 2006, 7:66.
18. Pecks U., Brieger M., Schiessl B., Bauerschlag D.O., Piroth D., Bruno B., et al. Maternal and fetal cord blood lipids in intrauterine growth restriction. J Perinat Med 2012, 40:287-296.
19. Kaser S., Ebenbichler C.F., Wolf H.J., Sandhofer A., Stanzl U., Ritsch A., et al. Lipoprotein profile and cholesteryl ester transfer protein in neonates. Metabolism 2001, 50:723-728.
20. Napoli C., D'Armiento F.P., Mancini F.P., Postiglione A., Witztum J.L., Palumbo G., et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Investig 1997, 100:2680-2690.
21. Herrera E. Implications of dietary fatty acids during pregnancy on placental, fetal and postnatal development-a review. Placenta 2002, 23(Suppl. A).
22. Dube E., Ethier-Chiasson M., Lafond J. Modulation of cholesterol transport by insulin-treated gestational diabetes mellitus in human full-term placenta. Biol Reprod 2013, 88:16.
23. Kotowski I.K., Pertsemlidis A., Luke A., Cooper R.S., Vega G.L., Cohen J.C., et al. A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. Am J Hum Genet 2006, 78:410-422.